| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | PETRI BIO INC | 370 AMAPOLA AVE | TORRANCE | CA | 90501-7239 | LOS ANGELES | USA | R43HD107885 | Live microbial therapeutics for enzyme replacement therapy against homocystinuria | 000 | 1 | NIH | 2/27/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $55,000 ) |
| | 2022 | 2022 | PETRI BIO INC. | 370 AMAPOLA AVE STE 100 | TORRANCE | CA | 90501-7239 | LOS ANGELES | USA | R43HD107885 | Live microbial therapeutics for enzyme replacement therapy against homocystinuria | 001 | 1 | NIH | 4/29/2022 | $55,000 |
| | 2022 | 2021 | PETRI BIO INC. | 370 AMAPOLA AVE STE 100 | TORRANCE | CA | 90501-7239 | LOS ANGELES | USA | R43HD107885 | Live microbial therapeutics for enzyme replacement therapy against homocystinuria | 000 | 1 | NIH | 3/10/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $306,931 ) |
| | 2021 | 2021 | PETRI BIO LLC | 1701 PURDUE AVE APT 1 | LOS ANGELES | CA | 90025-4298 | LOS ANGELES | USA | R43HD107885 | Live microbial therapeutics for enzyme replacement therapy against homocystinuria | 000 | 1 | NIH | 9/20/2021 | $306,931 |
|
|
